Related Experiment Video
Updated: Aug 31, 2025

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
Lynch syndrome; towards more personalized management?
Joan Llach1, Maria Pellisé1, Kevin Monahan2
1Department of Gastroenterology, Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), University of Barcelona, Barcelona, Spain.
Lynch syndrome, an inherited condition, significantly increases colorectal and endometrial cancer risks. Personalized management, including surveillance and preventive strategies, is crucial for reducing cancer mortality in affected individuals.
Area of Science:
- Oncology
- Genetics
- Preventive Medicine
Background:
- Lynch syndrome is the most common hereditary cause of colorectal and endometrial cancers.
- It confers a high lifetime cancer risk, up to 70% for colorectal cancer.
- Early diagnosis enables crucial preventive measures to reduce cancer incidence and mortality.
Purpose of the Study:
- To review the current understanding of Lynch syndrome and its associated cancer risks.
- To evaluate the effectiveness of existing surveillance and preventive strategies.
- To advocate for a personalized management approach for individuals with Lynch syndrome.
Main Methods:
- Literature review of Lynch syndrome diagnosis, management, and outcomes.
- Analysis of cancer risks, surveillance effectiveness, and preventive interventions.
- Synthesis of evidence regarding gene-specific risks and environmental modifiers.
Main Results:
- Colonoscopic surveillance, aspirin use, and prophylactic surgeries reduce cancer mortality.
- Cancer risks are gene-specific and influenced by environmental factors.
- Balancing surveillance benefits against over-diagnosis risks is essential.
Conclusions:
- Personalized management strategies are recommended for Lynch syndrome.
- Tailoring interventions based on individual risk profiles optimizes outcomes.
- Further research is needed to refine personalized approaches and evidence-based guidelines.
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cystic Fibrosis: Management
Sinus disease and chronic...
Barrett Esophagus-II: Clinical Manifestations and Management
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...

